Press Releases

PExA receives broad attention in Australia – seen as having significant potential for earlier detection of silicosis

PExA’s technology is receiving broad attention in Australia following promising research at The Prince Charles Hospital in Brisbane. Researchers see potential for a simple, non-invasive breath test to identify early biological changes associated with silicosis – potentially enabling earlier detection and, in the longer term, helping to prevent the disease. During the summer, the research…

Read more

PExA signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million

PExA AB has signed an agreement with one of the world’s ten largest pharmaceutical companies regarding the delivery, installation and rental of ten PExA 2.1 systems for use in an international clinical study in idiopathic pulmonary fibrosis (IPF). Under the agreement, the customer will rent ten systems for a period of 18 months. The total…

Read more

New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases

A new doctoral thesis from Lund University, entirely based on PExA’s technology for analysing exhaled particles from the lungs, strengthens the view of PExA as a platform for non-invasive biomarker analysis. The thesis shows how PExA-based breath samples can provide biologically relevant information across four different areas of lung disease: infection/COVID-19, lung transplantation, acute lung…

Read more

TV4 News highlights research where PExA’s technology is being used for future early detection of lung cancer

During Sunday, Swedish national broadcaster TV4 News featured research where PExA’s technology is being used in several of its national news broadcasts. The report focused on future possibilities for detecting lung diseases such as COPD and lung cancer at an earlier stage through analysis of exhaled air. In the feature, titled “New technology may detect…

Read more